Welch Capital Partners welchcapital.com

See All Exits Recent Exits

Phone:

Fax:

600 Lexington Avenue
 New York, 10022-7608
 New York, United States

Welch Capital Partners - Investments & Acquisitions

Show Real Data Welch Capital Partners Investments
See all Recent Investments
Date Company Round Amount Co-investors
2004-12-13Penwest PharmaceuticalsUnattributed VC - III$35MAccipiter Capital Management, Alydar Partners, Bain Capital Public Equity, Balyasny Asset Management, Colonial Fund, D.B. Zwirn & Co, Dorset Management Corporation, Highbridge Capital Management, Kilkenny Capital Management, Knott Partners, MPM Capital, Och-Ziff Capital Management Group, OrbiMed Advisors, and Tekla Capital Management
2003-08-21Penwest PharmaceuticalsUnattributed VC - II$52.66MAllianz, Deephaven Capital Management, Dorset Management Corporation, Downsview Capital, Highbridge Capital Management, Knott Partners, Mainfield Enterprises, Narragansett Asset Management, OppenheimerFunds, Perceptive Advisors, Point72 Asset Management, ProMed Capital, Putnam Investments, RS Emerging Growth Fund, RS Investments, Rx Health Management, and SF Capital Group
2003-07-07Sonus PharmaceuticalsUnattributed VC - III$14.24MBain Capital Public Equity, Cantara, Clarion Capital Partners, DKR Saturn Management, Domain Associates, MPM Capital, Perceptive Advisors, ProMed Capital, Quogue Capital, Symmetry Capital Management, and Ursus Capital Management
2002-11-18RTI SurgicalPIPE$27.55MAdler & Co., AWM Investment Company, Downsview Capital, Federated Equity Funds - Federated Kaufmann Fund, Federated Investors, Highbridge Capital Management, Highline Capital Management, Pequot Capital Mangement, Presidio Geary Management, Siparex, and Zweig-DiMenna Associates
2001-06-15Guilford PharmaceuticalsUnattributed VC - II$59.1MBayStar Capital, Domain Associates, Downsview Capital, Elliott Management, First-Tier Biotechnology Partners, Franklin Advisers, Franklin Templeton, Gryphon Investors, Heights Capital Management, Langley Capital, Lyxor Asset Management SA, OppenheimerFunds, Paramount Capital Asset Management, Strong River Investments, T. Rowe Price, and The Halifax Group
See all 5 investments